Abstract
We identified over 100 recipients of rabies vaccine (human diploid cell vaccine) and recruited them as plasma donors. Some were plasmapheresed at static centres, others by mobile teams. The operation of these teams is described in detail. No plasma was sent to the Fractionation Centre until the date of vaccination had been checked. Assay results showed that the majority of plasma collected between four and 20 weeks after the second dose of vaccine contained 6 or more IU/ml.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bahmanyar M., Fayaz A., Nour-Salehi S., Mohammadi M., Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA. 1976 Dec 13;236(24):2751–2754. [PubMed] [Google Scholar]
- Kuwert E. K., Werner J., Marcus I., Cabasso V. J. Immunization against rabies with rabies immune globulin, human (RIGH) and a human diploid cell strain (HDCS) rabies vaccine. J Biol Stand. 1978 Jul;6(3):211–219. doi: 10.1016/s0092-1157(78)80007-9. [DOI] [PubMed] [Google Scholar]
- Lundsgaard-Hansen P. Volume limitations of plasmapheresis. Vox Sang. 1977;32(1):20–25. doi: 10.1111/j.1423-0410.1977.tb00599.x. [DOI] [PubMed] [Google Scholar]
- Turner G. S. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol. 1978 Sep;40(3):595–604. doi: 10.1099/0022-1317-40-3-595. [DOI] [PubMed] [Google Scholar]